SCHEMBL7529688

SCHEMBL7529688

CCCC[Si](O[Si](CCCC)(c1ccccc1)c1ccccc1)(c1ccccc1)c1ccccc1.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.37
PTGS2 P35354 1/20 0.36
TSHR P16473 1/20 0.34
CETP P11597 3/20 0.33
SOAT1 P35610 1/20 0.33
PCSK9 Q8NBP7 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ALOX12 P18054 1/20 0.33
CRHBP P24387 1/20 0.33
HTT P42858 1/20 0.33
CRHR2 Q13324 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NAAA Q02083 1/20 0.33
AR P10275 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875722 0.98 LTA4H (0.38) LTA4HPTGS2TSHRCETPSOAT1
SCHEMBL9334179 0.85 DRD2 (0.34) LTA4HPTGS2CYP1A2CYP2C9CYP2C19
SCHEMBL2655578 0.84 LTA4H (0.37) LTA4HPTGS2TSHRSOAT1PCSK9
SCHEMBL18328936 0.83 SOAT1 (0.32) LTA4HPTGS2SOAT1
SCHEMBL7408504 0.82 LTA4H (0.36) LTA4HPTGS2TSHRSOAT1PCSK9
SCHEMBL2655575 0.82 LTA4H (0.36) LTA4HPTGS2TSHRSOAT1PCSK9
SCHEMBL3481751 0.82 LTA4H (0.36) LTA4HPTGS2TSHRSOAT1PCSK9
SCHEMBL3481385 0.81 LTA4H (0.39) LTA4HPTGS2TSHRSOAT1CYP1A2
SCHEMBL28174657 0.79 LTA4H (0.34) LTA4HPTGS2TSHRSOAT1PCSK9
SCHEMBL28039482 0.79 PTGS2 (0.37) LTA4HPTGS2TSHRSOAT1PCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1185539-A1 ORGANOSILYL COMPOUNDS HAVING NUCLEAR HORMONE RECEPTOR MODULATING ACTIVITY Allergan Sales, Inc. (US) 2002-03-13 EP disclosed
EP-1185277-A1 METHODS FOR MODULATING FXR RECEPTOR ACTIVITY Allergan Sales, Inc. (US) 2002-03-13 EP disclosed
WO-2000076523-A1 METHODS FOR MODULATING FXR RECEPTOR ACTIVITY ALLERGAN SALES, INC. (US) 2000-12-21 WO disclosed
WO-2000077011-A1 ORGANOSILYL COMPOUNDS HAVING NUCLEAR HORMONE RECEPTOR MODULATING ACTIVITY ALLERGAN SALES, INC. (US) 2000-12-21 WO disclosed